Oral biofluid levels of activin-a and interleukin-1beta in stage III periodontitis
dc.authorscopusid | Gülnur Emingil / 35609889700 | |
dc.authorwosid | Gülnur Emingil / IRR-0557-2023 | |
dc.contributor.author | Özden, Can | |
dc.contributor.author | Afacan, Beral | |
dc.contributor.author | İlhan, Harika Atmaca | |
dc.contributor.author | Köse, Timur | |
dc.contributor.author | Emingil, Gülnur | |
dc.date.accessioned | 2025-04-17T08:41:03Z | |
dc.date.available | 2025-04-17T08:41:03Z | |
dc.date.issued | 2025 | |
dc.department | İstinye Üniversitesi, Diş Hekimliği Fakültesi, Klinik Bilimler Bölümü | |
dc.description.abstract | Objectives Activin-A belongs to the transforming growth factor-beta superfamily and is a multifunctional cytokine that plays a role in inflammation, immune response, tissue repair and regeneration. Proinflammatory cytokine interleukin-1beta (IL-1 beta) can increase Activin-A expression in various cell types. This study aims to evaluate gingival crevicular fluid (GCF) and salivary Activin-A and IL-beta levels in stage III periodontitis. Materials and methods 23 patients with stage III periodontitis, 26 with gingivitis and 26 periodontally healthy individuals were included. Full-mouth clinical periodontal indices were recorded, unstimulated whole saliva and GCF samples were obtained, Activin-A and IL-1 beta total amounts were determined by ELISA. Statistical comparisons were performed using non-parametric tests. Receiver operating characteristics curve was used for estimating the area under the curve (AUC). Results Periodontitis group exhibited significantly lower GCF Activin-A levels but higher IL-1 beta levels than the periodontally healthy group (p < 0.05). Gingivitis group had similar GCF Activin-A and IL-1 beta levels to the periodontitis and periodontally healthy groups (p > 0.05). Salivary Activin-A and IL-1 beta concentrations were similar among study groups (p > 0.05). GCF Activin-A level showed an excellent diagnostic performance (an AUC value of 0.82 with 87% sensitivity) to discriminate periodontitis from periodontal health. ConclusionsFor the first time, this study demonstrated oral biofluid levels of Activin-A in periodontal health and diseases. Within the limits of the study, it might be suggested that diseased sites in periodontitis are associated with reduced Activin-A and increased IL-1 beta levels in GCF.Clinical relevance.Reduced GCF Activin-A levels and the accompanying increase in IL-1 beta might be associated with diseased sites in stage III periodontitis. ConclusionsFor the first time, this study demonstrated oral biofluid levels of Activin-A in periodontal health and diseases. Within the limits of the study, it might be suggested that diseased sites in periodontitis are associated with reduced Activin-A and increased IL-1 beta levels in GCF.Clinical relevance.Reduced GCF Activin-A levels and the accompanying increase in IL-1 beta might be associated with diseased sites in stage III periodontitis. ConclusionsFor the first time, this study demonstrated oral biofluid levels of Activin-A in periodontal health and diseases. Within the limits of the study, it might be suggested that diseased sites in periodontitis are associated with reduced Activin-A and increased IL-1 beta levels in GCF.Clinical relevance.Reduced GCF Activin-A levels and the accompanying increase in IL-1 beta might be associated with diseased sites in stage III periodontitis. | |
dc.description.sponsorship | Aydın Adnan Menderes University | |
dc.identifier.citation | Özden, C., Afacan, B., İlhan, H. A., Köse, T., & Emingil, G. (2025). Oral biofluid levels of Activin-A and interleukin-1beta in stage III periodontitis. Clinical Oral Investigations, 29(1), 1-11. | |
dc.identifier.doi | 10.1007/s00784-024-06088-1 | |
dc.identifier.endpage | 11 | |
dc.identifier.issn | 1432-6981 | |
dc.identifier.issn | 1436-3771 | |
dc.identifier.issue | 1 | |
dc.identifier.pmid | 39656274 | |
dc.identifier.scopus | 2-s2.0-85211498528 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 1 | |
dc.identifier.uri | http://dx.doi.org/10.1007/s00784-024-06088-1 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/6171 | |
dc.identifier.volume | 29 | |
dc.identifier.wos | WOS:001375556200001 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | Emingil, Gülnur | |
dc.institutionauthorid | Gülnur Emingil / 0000-0002-4869-9629 | |
dc.language.iso | en | |
dc.publisher | Springer science and business media deutschland GmbH | |
dc.relation.ispartof | Clinical oral investigations | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Cytokine | |
dc.subject | Gingival Crevicular Fluid | |
dc.subject | Inflammation | |
dc.subject | Periodontitis | |
dc.subject | Saliva | |
dc.title | Oral biofluid levels of activin-a and interleukin-1beta in stage III periodontitis | |
dc.type | Article |